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The physiologic response to traumatic injury may alter the disposition of drugs and thereby affect their
therapeutic or toxic potential. A study was conducted in 10 mongrel dogs to determine the effect of experimental
hemorrhagic shock with resuscitation on the pharmacokinetics of gentamicin and cefazolin. Single simulta-
neous intravenous doses of gentamicin (3 mg/kg) and cefazolin (25 mg/kg) were administered to each animal on
an initial study day, after which serial blood and urine collections were performed. After 1 week, a standard
hemorrhagic shock model was applied to each animal. Shock was continued for 1 h, after which the animal was
resuscitated with either whole blood or saline. After stabilization for 20 min, a second dose of gentamicin and
cefazolin was administered, and blood and urine were again collected. Drug clearance was not significantly
altered, except for that of cefazolin after saline resuscitation, for which there was a significant increase in drug
clearance. After both methods of resuscitation an increase in the volume of distribution was noted for cefazolin
and gentamicin. Drug half-life was noted to be increased after shock for cefazolin by both resuscitation methods
and for gentamicin after shock by saline resuscitation. Although alterations of pharmacokinetic parameters
were noted, mean concentrations of gentamicin and cefazolin in serum were similar for pre- and postshock
phases.
The physiologic response to traumatic injury may impose
alterations in the disposition of drugs that may affect their
therapeutic or toxic potential. A common result of traumatic
injury is hemorrhage, which may proceed to shock. With
hemorrhagic shock, immediate changes in cardiovascular
parameters have been well documented and include de-
crease in cardiac output, blood volume, increase in systemic
vascular resistance and redistribution of blood flow (6).
These changes then cause an alteration in the blood flow to
major organs. Blood flow to heart, liver, and brain is
maintained at the expense of the kidneys, gut, and skin (6).
This latter effect is mediated by the sympathetic, mineralo-
corticoid, and antidiuretic hormone responses (1). A de-
crease in blood volume and renal blood flow also stimulates
the antidiuretic hormone, resulting in lowered urine output.
As a result of these responses to hemorrhagic shock,
alterations in drug disposition relative to that in nonshock
states may occur. The disposition of drugs that are elimi-
nated primarily by renal excretion is likely to be affected.
Concentrations of renally eliminated agents in serum may be
increased when given after hemorrhagic shock compared
with those in the absence of shock. Therefore, traditional
doses of renally eliminated drugs may prove excessive in the
face of hemorrhagic shock and may present a greater poten-
tial for toxicity.
After traumatic injury, in which hemorrhage and shock are
frequently present, antimicrobial agents are often necessary
to prevent the development of subsequent infection. At
present, little information is available to suggest proper
dosage schedules of antimicrobial agents after hemorrhagic
shock and fluid resuscitation, particularly for renally ex-
* Corresponding author.
creted agents. Our intention was to examine the effect of
hemorrhagic shock with resuscitation on the disposition
(pharmacokinetics) of two commonly used antimicrobial
agents, cefazolin and gentamicin. These agents were chosen
for study because they are representatives of classes of
antimicrobial agents (1-lactams and aminoglycosides) that
are commonly used after traumatic injuries with bacterial
comtamination. Cephalosporins such as cefazolin are active
against most gram-positive bacteria, while most gram-
negative bacteria are susceptible to aminoglycosides.
MATERIALS AND METHODS
Study design. The pharmacokinetic profiles of cefazolin
sodium and gentamicin sulfate were determined in 10 adult
mongrel dogs after a single intravenous dose. Each animal
was studied on 2 days separated by 1 week. On study day 1
the dogs were treated under the conditions described below,
in the absence of hemorrhagic shock; and on day 2 the dogs
were treated following resuscitation from hemorrhagic
shock. Each animal served as its own control. The study was
approved by the Animal Use Review Committee at the
Medical College of Georgia.
On each study day the animals were anesthetized with
sodium pentobarbital, intubated, and placed in a supine
position. Ventilatory assistance was begun if the respiratory
rate was less than 5 respirations per minute. Intravenous and
intraarterial catheters were placed for continuous monitoring
of arterial pressure, blood sampling, and fluid administra-
tion. All urine was collected on each study day through a
urethral catheter. Continuous monitoring of the electrocar-
diogram and arterial pressure (systolic, diastolic, and mean)
was performed with an oscilloscope and monitor (models
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FIG. 1. Mean concentration (with standard deviations) of
cefazolin (upper curves) and gentamicin (lower circles) in serum
prior to hemorrhagic shock (0) and after hemorrhagic shock with
whole blood resuscitation (0).
78304A, 78205B, and 78213C; Hewlett-Packard Co., Palo
Alto, Calif.).
After initial stabilization of each animal, base-line labora-
tory values including hematocrit, serum creatinine, total
protein, and albumin were determined. On each study day
cefazolin sodium (25 mg/kg) immediately followed by genta-
micin sulfate (3 mg/kg) were each administered intrave-
nously over 5 min. In previous studies it has been demon-
strated that cephalosporins (particularly cefazolin) do not
result in significant aminoglycoside inactivation (4, 7, 8).
Arterial blood samples were collected just before drug
administration and at 0, 5, 10, 15, 20, 30, and 45 min and 1,
1.5, 2.0, 2.5, 3.0, 4.0, and 6 h after gentamicin administration
was complete. Serum was separated and frozen at -25°C
until time of analysis. All urine was collected in 30-min
intervals for a total of 4 h, followed by two collections at 1-h
intervals. The volume from each collection was recorded,
and a fraction was frozen until analysis. At the completion of
the sampling period on day 1, the animals were allowed to
recover for 7 days before study day 2.
On study day 2, the animals were prepared as described
for study day 1. Large-bore (14-gauge) catheters were placed
in the left external jugular and common femoral veins. In
addition, a 14-gauge catheter was placed in the common
femoral artery and connected to the pressure-monitoring
aparatus. After 20 min of stabilization, each animal was
heparinized with 100 U of sodium heparin per kg of body
weight. By using a modification of the Wigger and Werle (10)
hemorrhagic shock model, hemorrhage was induced by
blood removal from the arterial catheter over a period of 15
to 20 min, until a mean arterial pressure of 50 mm Hg was
obtained. Hemorrhage to a mean arterial pressure of 50 mm
Hg was adequate to demonstrate significant shock, as well as
survivability after resuscitation (9-11). This pressure was
maintained for a period of exactly 1 h. At the end of this 1 h
the animals were resuscitated by intravenous administration
of fluids over 5 to 10 min.
The animals were divided into two groups to study resus-
citation techniques. Five dogs received fluid resuscitation
with 0.9% sodium chloride in a volume equal to three times
that of the blood removed (5). The remaining five animals
were resuscitated with 1 liter of 0.9% sodium chloride and
the entire volume of the previously withdrawn heparinized
whole blood. After a 20-min stabilization period, the antibi-
otics were administered as described above with the same
serum and urine sampling procedures. At the end of the
study, each animal was sacrificed.
Drug analysis. Cefazolin in serum and urine was assayed
by a reverse phase, high-performance liquid chromatogra-
phic technique (S. M. Bayoumi, J. J. Vallner, and J. T.
DiPiro, Int. J. Pharm. in press) with a pump (model 590;
Waters Associates, Inc., Milford, Mass.) with autosampler
(WISP), a UV detector (481 Lambdamax; Waters Associ-
ates), and a recorder-integrator (model 3390A; Hewlett-
Packard). A column (15 cm; C-18; Waters Associates) was
used with a mobile phase consisting of acetonitrile and 0.1 M
acetate buffer (pH 3.85) in a 11:89 ratio and with sulfameth-
oxazole serving as an internal standard. In previous studies
the sensitivity of this assay was 0.5 ,ug/ml, with coefficients
of variation (within-day) of 2.5 and 3.12% at 2 and 20 ,ug/ml,
respectively.
Gentamicin in serum was assayed by a fluorescence
polarization immunoassay (3), by using a fluorescence polar-
izer analyzer (TDX; Abbott Laboratories, Chicago, Ill.). The
technique allowed detection of gentamicin from 0.25 to 12
,ug/ml. Coefficients of variation (within-day) determined at
our institution over the 2- to 10-,ug/ml range were 2 to 3.5%.
Investigators have demonstrated previously (3) the speci-
ficity of this method and have shown negligible interference
by other aminoglycosides and a wide range of commonly
used drugs. A standard curve was prepared by using six
concentrations, between 0.25 and 12 jxg/ml.
Pharmacokinetic analysis. Pharmacokinetic parameters
were calculated for each animal on each day by using
noncompartmental analysis. Specifically, total clearance
(CL) and volume of distribution at steady state (Vss) were
calculated for each drug, as was the terminal elimination rate
constant (kel) and half-life (t1/2) (2). Renal clearance (CLR)
was calculated for cefazolin only because this agent is
known to have dual pathways of elimination that may be
altered by the model.
The areas under cefazolin and gentamicin serum concen-
tration versus time curves (AUCs) from 0 to 6 h after drug
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FIG. 2. Mean concentrations (with standard deviations) of
cefazolin (upper curves) and gentamicin (lower curves) in serum
prior to hemorrhagic shock (0) and after hemorrhagic shock with
saline resuscitation (0).
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TABLE 1. Mean pharmacokinetic parameters by method of resuscitation of cefazolin and gentamicin
Mean ± SD for pharmacokinetic parameters
Drug and
parameter Preshock Postshock
Saline Blood Saline Blood
Cefazolin
t1/2 (min) 85.6 ± 15.2 73.8 ± 14.6a 108.6 ± 28.9 96.3 ± 13.2
CL (mi/min per kg) 3.38 ± 1.05a 3.13 ± 0.76 2.75 ± 1.10 3.59 ± 0.78
CLR (mi/min per kg) 2.60 ± 0.56 2.61 ± 0.51 1.77 ± 0.75 2.52 ± 0.70
VS, (liter/kg) 0.286 ± 0.059 0.278 ± 0.063 0.329 ± 0.12 0.403 ± 0.056
Varea (liter/kg) 0.410 ± 0.094 0.332 ± 0.089a 0.427 ± 0.174 0.499 ± 0.098
Gentamicin
t112 (min) 96.1 ± 31.7- 106.8 ± 36.0 132.3 ± 39.3 107.5 ± 33.6
CL (mi/min per kg) 2.51 ± 0.41 2.88 ± 0.628 2.64 ± 0.75 3.28 ± 0.55
VSS (liter/kg) 0.264 + 0.039a 0.329 ± 0.067a 0.404 ± 0.120 0.370 ± 0.110
Varea (liter/kg) 0.351 + 0.081a 0.433 ± 0.124 0.450 ± 0.122 0.490 ± 0.093
a Indicates significant difference (P < 0.05) between pre- and postshock groups by paired t test.
administration were calculated by using a logarithmic trap-
ezoidal method and were corrected for the infusion time.
The AUC from 6 h to infinity after drug administration was
estimated by dividing the concentration at 6 h by kel. The
area under the curve of the product of concentration and
time versus time (area under the moment curve; AUMC)
from 0 to 6 h after drug administration was calculated by the
linear trapezoid method. The AUMC from 6 h to infinity
after drug administration was estimated from the 6-h con-
centration-time product divided by ke, and then added to the
6-h concentration divided by kel2.
The kej was calculated from the slope of the natural log of
serum concentration versus time plot from 2 to 6 h (log-linear
portion). The terminal t1/2 was defined as t112 = 0.693/kel. CL
was determined by dividing the dose administered by the
AUC. The volume of the distribution by area (Varea) was
calculated by dividing the dose administered by the product
of AUC and kel.
The CLR was calculated for cefazolin as the total amount
of drug excreted in the urine in 6 h divided by the AUC for
drug in serum from 0 to 6 h. V,. was calculated from the
following relationship: Vss = (dose x AUMC/AUC2) -
(dose x 5 min/2x AUC). This was expressed as liters per
kilogram of body weight (2).
Statistical analysis. Mean values for each parameter were
calculated for the animals in the saline and whole blood
resuscitation groups for each study day. Differences be-
tween pre- and postshock data were compared by the paired
t test. A P value of 0.05 was accepted as significant.
RESULTS
A total of 13 animals were entered into the trial, and 10
animals completed (6 male and 4 female) the trial. Of the
three deaths, two animals expired during the shock phase of
the study day 2, while one animal expired for unknown
reasons after the study day 1 was completed. The 10 anirnals
that completed the trial weighed a mean of 15.2 ± 3.9 kg
(range, 9.1 to 20.5 kg) and had normal values for the
laboratory screen tests.
To produce a mean arterial pressure of 50 mm Hg, a mean
of 634 ml of blood was withdrawn (range, 240 to 1180 ml)
which represented 25 to 59 ml/kg and was estimated to be
about 50% of the total blood volume. In several animals
additional blood (10 to 40 ml) was withdrawn to maintain
mean arterial pressure at 50 mm Hg for the specified time.
The preshock mean arterial pressure ranged from 105 to 120
mm Hg, which was brought to 50 mm Hg during the shock
phase and subsequently returned during the postshock phase
to 85 to 95 mm Hg in all animals.
Urine output averaged 2.8 ml/h during the shock phase
and then 54 ± 13 and 157 ± 65 ml/h during postshock for
saline and whole blood resuscitation, respectively (P <
0.01). Hematocrit was a mean of 34% in the preshock phase
and then 11.7 and 25% after saline and whole blood resus-
citation, respectively.
Pharmacokinetics. Mean concentrations of cefazolin and
gentamicin in serum are presented for animals that received
whole blood (Fig. 1) and saline (Fig. 2) resuscitation. Con-
centrations of each drug in serum after hemorrhagic shock
by both resuscitation methods were similar to those before
shock.
Mean pharmacokinetic parameters are given in Table 1.
For most comparisons, significant differences were not
noted. The mean cefazolin t112 was significantly higher
postshock (30% increase) after whole blood resuscitation.
With saline resuscitation, cefazolin t1/2 was increased 26%
postshock, but this difference was only significant at P < 0.1.
Because there were few observations, the probability of a
type II error is relatively high. Cefazolin CL was noted to be
significantly lower postshock with saline resuscitation; how-
ever, it was increased postshock with whole blood resusci-
tation (nonsignificant). For both saline and whole blood
resuscitation, the mean V,s increased postshock (14 and
43%, respectively), but these differences were not signifi-
cant. However, Varea was significantly increased postshock
with whole blood resuscitation (not significant with saline
resuscitation).
For gentamicin, the t1i2 was significantly longer postshock
after saline resuscitation (increase of 38%) but not with
whole blood resuscitation. 13y both resuscitation methods
the gentamicin CL during pre- and postshock was not
significantly different, while V, was significantly increased
(53 and 19%, respectively, with saline and whole blood
resuscitation). Varea was significantly increased after saline
resuscitation but not with whole blood resuscitation.
DISCUSSION
This model was designed to determine if hemorrhagic
shock and fluid resuscitation alters the pharmacokinetics of
two renally excreted antimicrobial agents (cefazolin and
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gentamicin). Overall, dramatic differences in concentrations
in serum pre- and postshock for saline and whole blood
resuscitation were not observed. Subtle differences in
pharmacokinetic parameters were observed.
For both resuscitation methods and with both agents
studied, increases in V., and Varea were noted. For these
agents, the V,, was related to the extracellular fluid volume.
This model therefore indicates that there is an increase in the
extracellular fluid volume after hemorrhagic shock and fluid
resusitation.
Cefazolin and gentamicin CLs were similar during pre-
and postshock, with the exception of cefazolin after whole
blood resuscitation, in which the CL postshock was signifi-
cantly reduced (19%o). Because these agents are primarily
excreted renally, our results indicate that renal drug excre-
tory capability is promptly restored by immediate fluid
resuscitation after hemorrhagic shock of relatively short
duration. With continued hemorrhage or in those cases in
which hemorrhage is accompanied by significant tissue or
organ trauma, the pharmacokinetics of cefazolin and genta-
micin could still be significantly affected. The infortnation
obtained from the results of this study suggests that in
humans in which significant blood loss occurs but in which
fluid is replaced promptly and in which there is minor tissue
injury, dosage regimens of cefazolin and gentamicin should
approximate those required in patients who have not had
significant hemmorrhage.
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